Document Detail

Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: Novel extracellular matrix modulating factors in cardiac remodelling.
MedLine Citation:
PMID:  22380695     Owner:  NLM     Status:  Publisher    
Cardiac remodelling is defined as changes in the size, shape, and function of the heart, which are most commonly caused by hypertension-induced left ventricular hypertrophy and myocardial infarction. Both neurohumoral and inflammatory factors have critical roles in the regulation of cardiac remodelling. A characteristic feature of cardiac remodelling is modification of the extracellular matrix (ECM), often manifested by fibrosis, a process that has vital consequences for the structure and function of the myocardium. In addition to established modulators of the ECM, the matricellular protein thrombospondin-4 (TSP-4) as well as the tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 has been recently shown to modulate cardiac ECM. TSP-4 null mice develop pronounced cardiac hypertrophy and fibrosis with defects in collagen maturation in response to pressure overload. TWEAK and Fn14 belong to the tumour necrosis factor superfamily of proinflammatory cytokines. Recently it was shown that elevated levels of circulating TWEAK via Fn14 critically affect the cardiac ECM, characterized by increasing fibrosis and cardiomyocyte hypertrophy in mice. Here we review the literature concerning the role of matricellular proteins and inflammation in cardiac ECM remodelling, with a special focus on TSP-4, TWEAK, and its receptor Fn14.
Erja Mustonen; Heikki Ruskoaho; Jaana Rysä
Related Documents :
21709575 - An atrial mass: the value of echocardiographic three-dimensional reconstruction.
15899365 - Comparative sensitivities between different plasma b-type natriuretic peptide assays in...
19155075 - The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial ...
12822655 - Nesiritide (bnp) in the management of postoperative cardiac patients.
14572165 - Combined oral contraceptives and the risk of myocardial infarction.
11533505 - Adjunctive therapies in the cath lab. successful thrombolysis using the combination of ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-1
Journal Detail:
Title:  Annals of medicine     Volume:  -     ISSN:  1365-2060     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8906388     Medline TA:  Ann Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Institute of Biomedicine, Department of Pharmacology and Toxicology, Biocenter Oulu, University of Oulu , Oulu , Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A contemporary viewpoint on 'aspirin resistance'
Next Document:  Vascular aging: chronic oxidative stress and impairment of redox signaling-consequences for vascular...